secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2026-04-03T23:59:59+00:00
Accession:  0001493152-26-015139
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Curtis Rosebraugh resigns from Ensysce Biosciences board
-----------------------------------------------------------------

- Resignation effective April 1, 2026; no reason given in notice.
- Rosebraugh served on the Nominating and Corporate Governance Committee until resignation.
- Resignation notice filed as Exhibit 17 to the 8-K.
- No replacement announced at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226015139/0001493152-26-015139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226015139/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-015139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer